Prevalence and association of polycystic ovary syndrome and hidradenitis suppurativa in underrepresented groups.
Hidradenitis suppurativa
PCOS
Polycystic ovary syndrome
Social determinants of health
Socioeconomic status
Journal
Archives of dermatological research
ISSN: 1432-069X
Titre abrégé: Arch Dermatol Res
Pays: Germany
ID NLM: 8000462
Informations de publication
Date de publication:
08 Jun 2024
08 Jun 2024
Historique:
received:
14
02
2024
accepted:
26
04
2024
revised:
20
04
2024
medline:
8
6
2024
pubmed:
8
6
2024
entrez:
8
6
2024
Statut:
epublish
Résumé
Hidradenitis suppurativa (HS) is an inflammatory disorder of follicular biology; androgens are believed to be involved in its pathogenesis. Polycystic ovary syndrome (PCOS) is similarly characterized by hyperandrogenism. Previous studies have found a lasting association of HS and PCOS. Socioeconomic status (SES) has been described as a comorbidity for both HS and PCOS that has not been accounted for in prior studies; we sought to investigate this association while adjusting for this. We also analyzed the prevalence of PCOS among HS patients. Using the All of Us database, female HS patients were stratified by PCOS diagnosis and compared by age, race, and ethnicity. Female HS patients were also nearest-neighbor propensity-score matched to controls at a 4:1 ratio, selecting for race, ethnicity, age, ever smoker, alcohol use disorder, obesity, type II diabetes, Medicaid status, and community deprivation index. Univariable and multivariable logistic regression was conducted to estimate the effect of HS on the presence of PCOS. The distribution of race among HS patients with PCOS was significantly different than HS patients without PCOS. A total of 1,022 female HS patients and 4,088 matched female controls were included. Significantly more patients carried a diagnosis of PCOS compared to controls (8.8% versus 4.3%, p < .001). In multivariable logistic regression, PCOS was significantly associated with HS [OR 1.71 (95% CI 1.34-2.17)]. This is the first study investigating the association of HS and PCOS within the All of Us database. We found that females with HS had a 1.34- to 2.17-fold increased odds of having PCOS, which is consistent with previous analyses. However, our analysis, in addition to controlling for common medical co-morbidities found in both HS and PCOS, also accounts for markers of SES at an individual and community level, further strengthening the association of HS with PCOS.
Identifiants
pubmed: 38850290
doi: 10.1007/s00403-024-02971-9
pii: 10.1007/s00403-024-02971-9
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
379Informations de copyright
© 2024. The Author(s).
Références
Garg A, Neuren E, Strunk A (2018) Hidradenitis Suppurativa is Associated with polycystic ovary syndrome: a Population-based analysis in the United States. J Invest Dermatol 138(6):1288–1292 PubMed PMID: 29378201. Epub 20180219. eng
doi: 10.1016/j.jid.2018.01.009
pubmed: 29378201
Socioeconomic Status and Polycystic Ovary Syndrome (2011) J Women’s Health 20(3):413–419 PubMed PMID: 21323584
doi: 10.1089/jwh.2010.2303
Merkin SS, Phy JL, Sites CK, Yang D (2016) Environmental determinants of polycystic ovary syndrome. Fertil Steril 106(1):16–24 PubMed PMID: 27240194. Epub 20160527. eng
doi: 10.1016/j.fertnstert.2016.05.011
pubmed: 27240194
Wertenteil S, Strunk A, Garg A (2018) Association of Low Socioeconomic Status with Hidradenitis Suppurativa in the United States. JAMA Dermatol 154(9):1086–1088 PubMed PMID: 30073254. PMCID: PMC6143032. eng
doi: 10.1001/jamadermatol.2018.2117
pubmed: 30073254
pmcid: 6143032
Brokamp C, Beck AF, Goyal NK, Ryan P, Greenberg JM, Hall ES Material community deprivation and hospital utilization during the first year of life: an urban population–based cohort study. Ann Epidemiol. 2019 2019/02/01/;30:37–43
Wolf WM, Wattick RA, Kinkade ON, Olfert MD (2018) Geographical prevalence of polycystic ovary syndrome as determined by region and Race/Ethnicity. Int J Environ Res Public Health. ;15(11). PubMed PMID: 30463276. PMCID: PMC6266413. Epub 20181120. eng.
Phan K, Charlton O, Smith SD (2020) Hidradenitis suppurativa and polycystic ovarian syndrome: systematic review and meta-analysis. Australas J Dermatol 61(1):e28–e33 PubMed PMID: 31261440. Epub 20190701. eng
doi: 10.1111/ajd.13110
pubmed: 31261440
Mintoff D, Agius R, Benhadou F, Das A, Frew JW, Pace NP (2023) Obesity and hidradenitis suppurativa: targeting meta-inflammation for therapeutic gain. Clin Exp Dermatol 48(9):984–990 PubMed PMID: 37171791. eng
doi: 10.1093/ced/llad182
pubmed: 37171791
Parker J, O’Brien C, Hawrelak J, Gersh FL (2022) Polycystic ovary syndrome: an evolutionary adaptation to Lifestyle and the Environment. Int J Environ Res Public Health. ;19(3). PubMed PMID: 35162359. PMCID: PMC8835454. Epub 20220125. eng.